Canary Capital Lays Groundwork for Staked Injective ETF with Delaware Filing
Asset manager Canary Capital has taken preliminary steps toward launching a staked Injective (INJ) exchange-traded fund by establishing the “Canary Staked INJ ETF” trust in Delaware, according to state corporate records.
The Delaware Division of Corporations filing, dated this week, represents a potential first move toward creating an investment product that would offer exposure to staked INJ tokens. This follows Canary Capital’s April filing for a similar TRX-based ETF that would stake Tron’s native token to generate yield.
While the Delaware trust formation is a standard preliminary step for ETF issuers, it doesn’t guarantee a product launch. The process typically precedes formal filings with the U.S. Securities and Exchange Commission. Several successful crypto ETFs, including spot Bitcoin products, began with similar Delaware trust formations.
The move comes as institutional interest grows in staking-based investment vehicles. 21Shares already offers a European exchange-traded product that tracks INJ and reinvests staking rewards.
